Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-07-06

Clinical Trial Update: Prevention of Acute Respiratory Infection in Taiwanese Institutionalized Elderly [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial for prevention of acute respiratory infection in elderly in Taiwan was withdrawn (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Harvard Medical School (HMS and HSDM) | Conditions: Acute Respiratory Infection | Phase 2, Phase 3 | Status: WITHDRAWN